{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:06:51Z","timestamp":1792739211867,"version":"4.5.0"},"reference-count":49,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"unspecified","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008637","name":"Center for Strategic Scientific Initiatives, National Cancer Institute","doi-asserted-by":"publisher","award":["CA111412"],"award-info":[{"award-number":["CA111412"]}],"id":[{"id":"10.13039\/100008637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008637","name":"Center for Strategic Scientific Initiatives, National Cancer Institute","doi-asserted-by":"publisher","award":["CA283892"],"award-info":[{"award-number":["CA283892"]}],"id":[{"id":"10.13039\/100008637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014039","name":"DOD Prostate Cancer Research Program","doi-asserted-by":"publisher","award":["W81XWH-22-1-0242"],"award-info":[{"award-number":["W81XWH-22-1-0242"]}],"id":[{"id":"10.13039\/100014039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2025,7,10]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Patients with head and neck squamous cell carcinoma (HNSCC), particularly the human papillomavirus negative (HPV\n                      <jats:sup>\u2212<\/jats:sup>\n                      ) subset, have a dismal prognosis. Furthermore, patients with Fanconi anemia (FA) have a genetic predisposition with a 500-fold to 700-fold higher incidence of HNSCC. Thus, novel and more efficacious therapies are needed. As current immunotherapies often fail due to suppressive elements in the tumor microenvironment (TME), we developed a trispecific killer engager (TriKE) to direct multiple signals to natural killer (NK) cells to overcome the hypoxic TME. This TriKE is comprised of a camelid nanobody that binds to CD16 on NK cells, an interleukin (IL)-15 moiety, and another novel camelid nanobody that binds to the B7-H3 antigen, which is highly and specifically expressed on the tumor cell surface.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The B7H3 TriKE was generated using a mammalian expression system. Its functionality was evaluated using flow cytometry-based NK cell degranulation, cytokine production, proliferation and live cell imaging cytotoxicity assays. Models of acute and prolonged hypoxia (1% oxygen) were carried out to assess tumor killing. Tumor progression, NK cell persistence, and survival differences between IL-15-treated and TriKE-treated mice were studied using NOD-scidIL2Rg\n                      <jats:sup>null<\/jats:sup>\n                      (NSG) mice engrafted with human HNSCC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      High B7-H3 expression was found in HPV\n                      <jats:sup>\u2212<\/jats:sup>\n                      HNSCC cell lines, even when the FA gene was knocked out, and The Cancer Genome Atlas patient data showed that high B7-H3 expression predicted poor survival in patients with HPV\n                      <jats:sup>\u2212<\/jats:sup>\n                      HNSCC. Similar to the NK cell activity seen with healthy donors, the B7H3 TriKE enhanced activation, expansion and cytotoxicity of NK cells from patients with HPV\n                      <jats:sup>\u2212<\/jats:sup>\n                      HNSCC, a target population for this therapeutic. Additionally, the B7H3 TriKE improved NK cell cytotoxicity in a three-dimensional spheroid model of HNSCC. In both acute and prolonged hypoxia (1% oxygen), the B7H3 TriKE mediated enhanced tumor killing, mitigating impairment of NK cell cytotoxicity in hypoxia.\n                      <jats:italic>In vivo<\/jats:italic>\n                      , the B7H3 TriKE-treated mice demonstrated substantial antitumor activity and prolonged survival.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The B7H3 TriKE is a novel immunotherapeutic approach that can overcome hypoxic suppression of NK cells in the HNSCC TME. These highly translational studies present an innovative therapy for patients with HNSCC and will be developed further for clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2024-011370","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T06:50:19Z","timestamp":1753339819000},"page":"e011370","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancer"],"prefix":"10.1136","volume":"13","author":[{"given":"Melissa J","family":"Khaw","sequence":"first","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7021-968X","authenticated-orcid":false,"given":"Nicholas A","family":"Zorko","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"},{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0239-5440","authenticated-orcid":false,"given":"Philippa R","family":"Kennedy","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"},{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E","family":"Bendzick","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"},{"name":"Department of Obstetrics, Gynecology and Women\u2019s Health, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Shackelford","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"},{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Selleck","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"},{"name":"Department of Obstetrics, Gynecology and Women\u2019s Health, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hinderlie","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua T","family":"Walker","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Soignier","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley C","family":"Lyons","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise L","family":"Femino","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terran","family":"Stenger","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tumpa","family":"Dasgupta","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E","family":"Kotz","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"},{"name":"Department of Obstetrics, Gynecology and Women\u2019s Health, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihir","family":"Shetty","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shee Kwan","family":"Phung","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng Hock","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Electrical and Computer Engineering, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynhanh","family":"Lu","sequence":"additional","affiliation":[{"name":"Xcell Biosciences, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Lim","sequence":"additional","affiliation":[{"name":"Xcell Biosciences, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo P","family":"Provenzano","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, University of Minnesota Medical School Twin Cities, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Fujioka","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"},{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary B","family":"Davis","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"},{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A","family":"Geller","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"},{"name":"Department of Obstetrics, Gynecology and Women\u2019s Health, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E","family":"Wagner","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"},{"name":"Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret L","family":"MacMillan","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"},{"name":"Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5945-0634","authenticated-orcid":false,"given":"Martin","family":"Felices","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"},{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S","family":"Miller","sequence":"additional","affiliation":[{"name":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA"},{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"2026052108153099000_13.7.e011370.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00224-3"},{"key":"2026052108153099000_13.7.e011370.2","first-page":"67","volume-title":"Advances in cancer research","volume":"152","author":"Bhat","year":"2021"},{"key":"2026052108153099000_13.7.e011370.3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2026052108153099000_13.7.e011370.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41415-022-5166-x"},{"key":"2026052108153099000_13.7.e011370.5","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32871"},{"key":"2026052108153099000_13.7.e011370.6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13102371","article-title":"Recurrent\/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Big and Intriguing Challenge Which May Be Resolved by Integrated Treatments Combining Locoregional and Systemic Therapies","volume":"13","author":"Ionna","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026052108153099000_13.7.e011370.7","doi-asserted-by":"publisher","DOI":"10.1002\/lary.25726"},{"key":"2026052108153099000_13.7.e011370.8","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2009-0289"},{"key":"2026052108153099000_13.7.e011370.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.4596"},{"key":"2026052108153099000_13.7.e011370.10","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020500","article-title":"Molecular Diagnostics in Human Papillomavirus-Related Head and Neck Squamous Cell Carcinoma","volume":"9","author":"Wai","year":"2020","journal-title":"Cells"},{"key":"2026052108153099000_13.7.e011370.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912217"},{"key":"2026052108153099000_13.7.e011370.12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2016.05.026","article-title":"Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129","volume":"96","author":"Galloway","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026052108153099000_13.7.e011370.13","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr544"},{"key":"2026052108153099000_13.7.e011370.14","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28811"},{"key":"2026052108153099000_13.7.e011370.15","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12234"},{"key":"2026052108153099000_13.7.e011370.16","unstructured":"Mehta PA , Ebens C . Fanconi anemia. In: Adam MP , Feldman J , Mirzaa GM , et al , eds. GeneReviews. Seattle, Seattle (WA): University of Washington, 1993."},{"key":"2026052108153099000_13.7.e011370.17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1259"},{"key":"2026052108153099000_13.7.e011370.18","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008918223334"},{"key":"2026052108153099000_13.7.e011370.19","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20998"},{"key":"2026052108153099000_13.7.e011370.20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000477097","article-title":"Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer","volume":"40","author":"Wuerdemann","year":"2017","journal-title":"Oncol Res Treat"},{"key":"2026052108153099000_13.7.e011370.21","first-page":"46","article-title":"Immunotherapy for hematological malignancies","volume":"1","author":"Dong","year":"2019","journal-title":"J Life Sci (Westlake Village)"},{"key":"2026052108153099000_13.7.e011370.22","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10030655","article-title":"Assessing the Future of Solid Tumor Immunotherapy","volume":"10","author":"Guha","year":"2022","journal-title":"Biomedicines"},{"key":"2026052108153099000_13.7.e011370.23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10555-017-9694-9","article-title":"Checkpoint immunotherapy in head and neck cancers","volume":"36","author":"Zolkind","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"2026052108153099000_13.7.e011370.24","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3390\/jcm12062173","article-title":"Advances in CAR-T Cell Therapy in Head and Neck Squamous Cell Carcinoma","volume":"12","author":"Wang","year":"2023","journal-title":"JCM"},{"key":"2026052108153099000_13.7.e011370.25","first-page":"77","article-title":"Cetuximab: its unique place in head and neck cancer treatment","volume":"7","author":"Specenier","year":"2013","journal-title":"Biologics"},{"key":"2026052108153099000_13.7.e011370.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32591-7"},{"key":"2026052108153099000_13.7.e011370.27","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100930","article-title":"NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis","volume":"14","author":"Nersesian","year":"2021","journal-title":"Transl Oncol"},{"key":"2026052108153099000_13.7.e011370.28","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1200\/JCO.2023.41.16_suppl.2563","article-title":"Pan-cancer analysis of natural killer (NK) cell infiltration in human malignancies: Molecular features and clinical implications","volume":"41","author":"Zorko","year":"2023","journal-title":"JCO"},{"key":"2026052108153099000_13.7.e011370.29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.757047","article-title":"Multi-Omics Data Analyses Identify B7-H3 as a Novel Prognostic Biomarker and Predict Response to Immune Checkpoint Blockade in Head and Neck Squamous Cell Carcinoma","volume":"12","author":"Lin","year":"2021","journal-title":"Front Immunol"},{"key":"2026052108153099000_13.7.e011370.30","doi-asserted-by":"crossref","DOI":"10.3390\/genes12040548","article-title":"Generating New FANCA-Deficient HNSCC Cell Lines by Genomic Editing Recapitulates the Cellular Phenotypes of Fanconi Anemia","volume":"12","author":"Errazquin","year":"2021","journal-title":"Genes (Basel)"},{"key":"2026052108153099000_13.7.e011370.31","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0837"},{"key":"2026052108153099000_13.7.e011370.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01065-5"},{"key":"2026052108153099000_13.7.e011370.33","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3684-7_15"},{"key":"2026052108153099000_13.7.e011370.34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"2026052108153099000_13.7.e011370.35","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092659","article-title":"NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo","volume":"12","author":"Vallera","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026052108153099000_13.7.e011370.36","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn1849","article-title":"Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments","volume":"10","author":"Kennedy","year":"2024","journal-title":"Sci Adv"},{"key":"2026052108153099000_13.7.e011370.37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.molimm.2022.02.015","article-title":"Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy","volume":"144","author":"Zhang","year":"2022","journal-title":"Mol Immunol"},{"key":"2026052108153099000_13.7.e011370.38","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19094-0","article-title":"Cryopreservation impairs 3-D migration and cytotoxicity of natural killer cells","volume":"11","author":"Mark","year":"2020","journal-title":"Nat Commun"},{"key":"2026052108153099000_13.7.e011370.39","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-2451"},{"key":"2026052108153099000_13.7.e011370.40","first-page":"5183","article-title":"Overexpression of B7-H3 as an opportunity for targeted therapy in head and neck cancers","volume":"11","author":"Hu","year":"2019","journal-title":"Am J Transl Res"},{"key":"2026052108153099000_13.7.e011370.41","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3892\/ijo.2011.949","article-title":"Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis","volume":"38","author":"Katayama","year":"2011","journal-title":"Int J Oncol"},{"key":"2026052108153099000_13.7.e011370.42","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1158\/2326-6066.CIR-24-0273","article-title":"A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate Cancer","volume":"13","author":"Phung","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"2026052108153099000_13.7.e011370.43","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113285","article-title":"The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy","volume":"12","author":"Quatrini","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026052108153099000_13.7.e011370.44","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-022-01672-z","article-title":"NK cells and solid tumors: therapeutic potential and persisting obstacles","volume":"21","author":"Tong","year":"2022","journal-title":"Mol Cancer"},{"key":"2026052108153099000_13.7.e011370.45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064835","article-title":"Hypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells","volume":"8","author":"Sarkar","year":"2013","journal-title":"PLoS One"},{"key":"2026052108153099000_13.7.e011370.46","doi-asserted-by":"publisher","DOI":"10.1038\/S41588-018-0318-2"},{"key":"2026052108153099000_13.7.e011370.47","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-021-00332-6","article-title":"A comprehensive comparison between camelid nanobodies and single chain variable fragments","volume":"9","author":"Asaadi","year":"2021","journal-title":"Biomark Res"},{"key":"2026052108153099000_13.7.e011370.48","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0816-5","article-title":"High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation","volume":"7","author":"MacGregor","year":"2019","journal-title":"J Immunother Cancer"},{"key":"2026052108153099000_13.7.e011370.49","doi-asserted-by":"crossref","DOI":"10.4161\/2162402X.2014.977164","article-title":"A novel subset of B7-H3+CD14+HLA-DR\u2212\/low myeloid-derived suppressor cells are associated with progression of human NSCLC","volume":"4","author":"Zhang","year":"2015","journal-title":"Oncoimmunology"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2024-011370","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:15:59Z","timestamp":1779376559000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2024-011370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,23]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/jitc-2024-011370"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2024-011370","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}